longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

BioMarin Pharma

BMRN

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI
Share your thoughts

What's on your mind?

0 / 2,000
  • L
    lyhalfwayMar 17 at 03:16 AM

    BMNR Extreme Value Deduction 3.17

    Last week's analysis indicated that both ETH and BMNR were in a bottoming phase, reflecting that even more negative macro crises did not push ETH down to its previous low of 1.7k. It was also mentioned that "this position is like a spring compressed into a very tight range, with limited downside but accumulating upward potential." The crypto rebound over the past two days has confirmed this judgment, with BTC breaking through 75k and ETH approaching 2.4k, both challenging the huge max pain of the 3.27 options chain. Meanwhile, there has been progress on the regulatory front, with policymakers gathering in DC this week...

    图片 1,共 2 张
    图片 2,共 2 张
    ETH相关分析
  • M
    Moose_Feb 26 at 03:13 AM

    Next catalyst for $BitMine Immersion Tech(BMNR.US) : Feb 28 PDUFA date for Ascendis Pharma's TransCon CNP . Bernstein says 90% approval probability. If approved, BMRN down low single digits. If CRL, up high single digits. Playing the binary event?